Oppenheimer & Co. Inc. lessened its holdings in Metlife Inc (NYSE:MET) by 0.4% during the fourth quarter, HoldingsChannel reports. The firm owned 285,710 shares of the financial services provider’s stock after selling 1,247 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Metlife were worth $14,446,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the business. Sentry Investment Management LLC boosted its holdings in shares of Metlife by 0.8% during the 2nd quarter. Sentry Investment Management LLC now owns 82,321 shares of the financial services provider’s stock valued at $4,523,000 after acquiring an additional 690 shares in the last quarter. QS Investors LLC boosted its holdings in shares of Metlife by 6.0% during the 2nd quarter. QS Investors LLC now owns 17,337 shares of the financial services provider’s stock valued at $952,000 after acquiring an additional 988 shares in the last quarter. Cowen Prime Services LLC boosted its holdings in shares of Metlife by 16.0% during the 3rd quarter. Cowen Prime Services LLC now owns 7,250 shares of the financial services provider’s stock valued at $377,000 after acquiring an additional 1,000 shares in the last quarter. Xact Kapitalforvaltning AB boosted its holdings in shares of Metlife by 0.7% during the 3rd quarter. Xact Kapitalforvaltning AB now owns 152,710 shares of the financial services provider’s stock valued at $7,933,000 after acquiring an additional 1,004 shares in the last quarter. Finally, First National Trust Co. boosted its holdings in shares of Metlife by 1.6% during the 3rd quarter. First National Trust Co. now owns 63,661 shares of the financial services provider’s stock valued at $3,307,000 after acquiring an additional 1,019 shares in the last quarter. 76.36% of the stock is currently owned by hedge funds and other institutional investors.

Several equities research analysts recently weighed in on the company. Goldman Sachs Group assumed coverage on Metlife in a report on Wednesday, October 18th. They set a “conviction-buy” rating and a $61.00 price objective on the stock. B. Riley reissued a “neutral” rating on shares of Metlife in a report on Monday, November 6th. Wells Fargo & Co reissued a “buy” rating on shares of Metlife in a report on Wednesday, October 18th. Zacks Investment Research raised Metlife from a “hold” rating to a “buy” rating and set a $60.00 price objective on the stock in a report on Thursday, November 9th. Finally, Morgan Stanley raised their price objective on Metlife from $55.00 to $56.00 and gave the company an “equal weight” rating in a report on Friday, November 3rd. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating and nine have issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $57.65.

Metlife Inc (MET) opened at $44.61 on Friday. The company has a market capitalization of $46,595.80, a PE ratio of -89.22, a price-to-earnings-growth ratio of 0.99 and a beta of 1.31. Metlife Inc has a twelve month low of $43.38 and a twelve month high of $55.91. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.31.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 3.59%. The ex-dividend date of this dividend is Friday, February 2nd. Metlife’s payout ratio is presently -320.00%.

TRADEMARK VIOLATION NOTICE: “Metlife Inc (MET) Shares Sold by Oppenheimer & Co. Inc.” was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://theolympiareport.com/2018/02/10/metlife-inc-met-shares-sold-by-oppenheimer-co-inc.html.

Metlife Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.